Precision Biosciences Disclosed Late-breaking Poster Presentation At The European Association For Study Of The Liver Congress 2024

Precision Biosciences Disclosed Late-breaking Poster Presentation At The European Association For Study Of The Liver Congress 2024

BenzingaMay 1 19:27

Precision Biosciences Initiated at Buy by Guggenheim

Precision Biosciences Initiated at Buy by Guggenheim

Dow JonesApr 30 19:51

Guggenheim Initiates Coverage On Precision BioSciences With Buy Rating, Announces Price Target of $19

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Precision BioSciences with a Buy rating and announces Price Target of $19.

Analyst UpgradesApr 30 19:41

HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences with a Buy and maintains $60 price target.

Analyst UpgradesApr 18 01:26

Buy Rating Affirmed for Precision BioSciences Amid Strong Gene Editing Prospects and Upcoming Milestones

TipRanksApr 17 21:05

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

GainersINVO Bioscience (NASDAQ:INVO) shares increased by 93.4% to $1.47 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.8 million. As per the press release

BenzingaApr 17 20:08